Skip to content
  • Tuesday, 29 September 2026
  • 3:43 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jul 25, 2026 0

A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jul 10, 2026 0

A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 29, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.

Lana Keisha Jun 22, 2026 0

A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 15, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput

Lana Keisha Jun 1, 2026 0

Immuto Scientific, a trailblazing company co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D., and CTO Daniel Benjamin, Ph.D., both…

Read More
Laboratory Automation & Robotics

How Immuto Scientific Pairs AI and Mass Spec for a Step Change in Protein Structure Throughput

Lana Keisha May 24, 2026 0

Immuto Scientific, a pioneering biotechnology firm co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO), and Daniel Benjamin,…

Read More
Laboratory Automation & Robotics

Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput

Lana Keisha May 15, 2026 0

Immuto Scientific, a trailblazing company co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO) and Daniel Benjamin, Ph.D.…

Read More
Laboratory Automation & Robotics

Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput

Lana Keisha May 8, 2026 0

In a significant development poised to accelerate drug discovery, Immuto Scientific, a biotech firm co-founded in 2018 by CEO Faraz…

Read More
Laboratory Automation & Robotics

Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput

Lana Keisha Apr 23, 2026 0

Immuto Scientific, a pioneering company co-founded in 2018 by electrical engineers Dr. Faraz A. Choudhury (CEO) and Dr. Daniel Benjamin…

Read More
Boosting one protein helps the brain fight Alzheimer’sModerna bets on mRNA’s second act with cancer, autoimmune programs and AI research platformFastAPI Cloud Revolutionizes Python Application Deployment, Streamlining Development for AI and Machine Learning ProjectsEarly Life Stress Linked to Long-Term Gastrointestinal Disorders Through Brain-Gut Communication Pathways
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m DealUnprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before DiagnosisAs the dream of the autonomous clinical trial dawns, agent supervision is today’s human jobNew Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
YOU MAY HAVE MISSED
Pharmaceutical R&D
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Teuku Ryan Sep 29, 2026
Stem Cell & Regenerative Medicine
Unprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before Diagnosis
Dwi Wanna Sep 29, 2026
Laboratory Automation & Robotics
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
Lana Keisha Sep 29, 2026
Neuroscience & Brain Research
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
Rifan Muazin Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ